Genetic testing for hereditary colorectal cancer: Challenges in identifying, counseling, and managing high-risk patients

Gastroenterology

Volumn 139, Issue 5, 2010, Pages

  Stoffel, Elena M ^a   Chittenden, Anu ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADENOMATOUS POLYP; BREAST CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RISK; CANCER SUSCEPTIBILITY; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; DNA SEQUENCE; ENDOMETRIUM CANCER; EXCISION REPAIR; FAMILIAL ADENOMATOUS POLYPOSIS; FAMILIAL CANCER; FAMILY HISTORY; GENE DELETION; GENE DUPLICATION; GENE MUTATION; GENETIC COUNSELING; GENETIC LINKAGE; GENETIC SCREENING; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HIGH RISK PATIENT; HUMAN; IMMUNOHISTOCHEMISTRY; JUVENILE POLYPOSIS; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; OVARY CANCER; PATIENT CARE; PATIENT IDENTIFICATION; PEUTZ JEGHERS SYNDROME; PHENOTYPE; POLYPOSIS; PRIORITY JOURNAL; RISK REDUCTION; SHORT SURVEY; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE;

EID: 78049472769     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.09.018     Document Type: Article

References (33)

1. American Society of Clinical Oncology policy statement update genetic testing for cancer susceptibility J Clin Oncol 21 2003 2397 2406
2. K.W. Jasperson, T.M. Tuohy, and D.W. Neklason Hereditary and familial colon cancer Gastroenterology 138 2010 2044 2058
3. American Gastroenterological Association medical position statement hereditary colorectal cancer and genetic testing Gastroenterology 121 2001 195 197
4. S. Syngal, E.A. Fox, and C. Li Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition testing JAMA 282 1999 247 253
5. A. Umar, C.R. Boland, and J.P. Terdiman Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability J Natl Cancer Inst 96 2004 261 268 (Pubitemid 38256271)
6. S.D. Ramsey, L. Clarke, and R. Etzioni Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis cancer Ann Intern Med 135 2001 577 588
7. M. Mvundura, S.D. Grosse, and H. Hampel The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer Genet Med 12 2010 93 104
8. W. Kievit, J.H. de Bruin, and E.M. Adang Cost effectiveness of a new strategy to identify HNPCC patients Gut 54 2005 97 102
9. H. Hampel, W.L. Frankel, and E. Martin Feasibility of screening for Lynch syndrome among patients with colorectal cancer J Clin Oncol 26 2008 5783 5788
10. J. Balmana, D.H. Stockwell, and E.W. Steyerberg Prediction of MLH1 and MSH2 mutations in Lynch syndrome JAMA 296 2006 1469 1478
11. S. Chen, W. Wang, and S. Lee Prediction of germline mutations and cancer risk in the Lynch syndrome JAMA 296 2006 1479 1487
12. R.A. Barnetson, A. Tenesa, and S.M. Farrington Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer N Engl J Med 354 2006 2751 2763
13. J.G. Monzon, C. Cremin, and L. Armstrong Validation of predictive models for germline mutations in DNA mismatch repair genes in colorectal cancer Int J Cancer 126 2010 930 939
14. J. Balmana, F. Balaguer, and S. Castellvi-Bel Comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patients J Med Genet 45 2008 557 563
15. A. de la Chapelle, and H. Hampel Clinical relevance of microsatellite instability in colorectal cancer J Clin Oncol 28 2010 3380 3387
16. C.R. Boland, and A. Goel Microsatellite instability in colorectal cancer Gastroenterology 138 2010 2073 2087
17. N.M. Lindor, K. Rabe, and G.M. Petersen Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X JAMA 293 2005 1979 1985
18. F.M. Giardiello, J.D. Brensinger, and G.M. Petersen The use and interpretation of commercial APC gene testing for familial adenomatous polyposis N Engl J Med 336 1997 823 827
19. S. Grover, E.M. Stoffel, and R.C. Mercado Colorectal cancer risk perception on the basis of genetic test results in individuals at risk for Lynch syndrome J Clin Oncol 27 2009 3981 3986
20. S.K. Peterson, B.G. Watts, and L.M. Koehly How families communicate about HNPCC genetic testing: findings from a qualitative study Am J Med Genet C Semin Med Genet 119 2003 78 86
21. E.M. Stoffel, B. Ford, and R.C. Mercado Sharing genetic test results in Lynch syndrome: communication with close and distant relatives Clin Gastroenterol Hepatol 6 2008 333 338
22. N.M. Lindor, G.M. Petersen, and D.W. Hadley Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review JAMA 296 2006 1507 1517
23. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in oncology: colorectal cancer screening http://www.nccn.org
24. D.W. Hadley, J.F. Jenkins, and E. Dimond Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer J Clin Oncol 22 2004 39 44
25. A. Wagner, I. van Kessel, and M.G. Kriege Long term follow-up of HNPCC gene mutation carriers: compliance with screening and satisfaction with counseling and screening procedures Fam Cancer 4 2005 295 300
26. C.H. Halbert, H. Lynch, and J. Lynch Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations Arch Intern Med 164 2004 1881 1887
27. E.M. Stoffel, R.C. Mercado, and W. Kohlmann Prevalence and predictors of appropriate colorectal cancer surveillance in lynch syndrome Am J Gastroenterol 105 2010 1851 1860
28. C. Engel, N. Rahner, and K. Schulmann Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer Clin Gastroenterol Hepatol 8 2010 174 182
29. H.J. Jarvinen, L. Renkonen-Sinisalo, and K. Aktan-Collan Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members J Clin Oncol 27 2009 4793 4797
30. K.M. Schmeler, H.T. Lynch, and L.M. Chen Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome N Engl J Med 354 2006 261 269
31. P.C. Schroy 3rd, A.F. Barrison, and B.S. Ling Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns Am J Gastroenterol 97 2002 1031 1036
32. S. Batra, H. Valdimarsdottir, and M. McGovern Awareness of genetic testing for colorectal cancer predisposition among specialists in gastroenterology Am J Gastroenterol 97 2002 729 733
33. United States Genetic Information Nondiscrimination Act of 2008 http://thomas.loc.gov/cgi-bin/bdquery/z?d110:HR00493:L&summ2=m& 2008